Stock Screener App

Frei - Play StoreApp Store

Installieren Installieren

Dow:

Nasdaq:

S&P 500:

WVE

$3.541.39%-0.05

Wave Life Sciences Ltd (WVE)

Date: O: H: L: C: Vol:

Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten

Oppenheimer cuts Wave Life Sciences stock price target on model update - Investing.com India

BlackRock reports a passive stake above 5% in Wave Life Sciences (WVE). - Stock Titan

BlackRock amends its Wave Life Sciences (WVE) stake disclosure for certain business units. - Stock Titan

Earnings call transcript: Wave Life Sciences tops Q3 2026 forecasts on revenue By Investing.com - Investing.com India

Wave Life Sciences Q3FY27 Results: Revenue up 73% YoY to $13.2 million - scanx.trade

Revenue rises with a $12M GSK milestone, but losses widen at Wave Life Sciences (WVE). - Stock Titan

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for - Zacks Investment Research

Obesity Clinical Trial and Competitive Landscape Surges as 200+ Companies Advance Next-Generation Therapies | DelveInsight - GlobeNewswire Inc.

Wave Life Sciences (WVE) Edges Up to $3.11 as Shares Hold Above Key Support - Fair Value Gap - https://www.dars.gov.et/

Wave Life Sciences (NasdaqGM:WVE) Stock Forecast & Analyst Predictions - Simply Wall Street

Form 4 Wave Life Sciences For: 10 October By Investing.com - Investing.com South Africa

Form 4 Wave Life Sciences For: 10 October By Investing.com - Investing.com UK

Form 4 Wave Life Sciences For: 7 October By Investing.com - Investing.com UK

Form 4 Wave Life Sciences For: 7 October By Investing.com - Investing.com Nigeria

Form 4 Wave Life Sciences For: 7 October By Investing.com - Investing.com Nigeria

Wave Life Sciences Director Christian Henry Awarded 10,700 RSUs and 64,000 Stock Options - Kalkine Media

A director receives a 10,700-share stock grant plus options at Wave Life Sciences (WVE). - Stock Titan

A director receives a 10,700-share stock grant and 64,000-share option at Wave Life Sciences (WVE). - Stock Titan

A director receives 10,700 stock units and a 64,000-share option at Wave Life Sciences (WVE). - Stock Titan

A 10,700-share stock grant joins 64,000 options for Wave Life Sciences (WVE) director Ken Takanashi. - Stock Titan

Wave Life Sciences Director Adrian Rawcliffe Awarded 10,700 RSUs and 64,000 Stock Options in 2026 Equity Grants - Kalkine Media

How Is GSK (LSE:GSK) Stock Reacting This Week To Its Wave Life Sciences Liver Candidate? - Kalkine Media

FDA supports a one-year data check for possible faster approval of Wave's treatment. - Stock Titan

This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

4 RNA Therapeutics Stocks Leading the Next Wave of Innovation - TradingView

Wave Life Sciences stock hits a 52-week low at USD 4.20 - AD HOC NEWS

Wave Life Sciences Names Monika Vnuk Chief Business Officer - citybiz

Wave Life Sciences appoints Monika Vnuk as chief business officer By Investing.com - Investing.com Australia

Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer - The Manila Times

Wave Life Sciences Appoints Monika Vnuk as Chief Business Officer - Quiver Quantitative

Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer - GlobeNewswire

Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer - GlobeNewswire

Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer - Yahoo Finance

Wave Life Sciences at Cantor conference: RNA editing gains traction By Investing.com - Investing.com Nigeria

Wave Life Sciences at Cantor conference: RNA editing gains traction By Investing.com - Investing.com Canada

Wave Life Sciences at Cantor conference: RNA editing gains traction - investing.com

Wave Life Sciences at Cantor conference: RNA editing gains traction By Investing.com - Investing.com UK

Wave Life Sciences stock holds steady ahead of Cantor healthcare conference appearance - ad-hoc-news.de

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference - GlobeNewswire

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference - Yahoo Finance

Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $14 - Moomoo

Wave Life Sciences stock trades quietly as investors focus on recent clinical progress - ad-hoc-news.de

WAVE Life Sciences (NASDAQ:WVE) Downgraded by Zacks Research to "Hold" - MarketBeat

Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares - Simply Wall Street

Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares - simplywall.st

Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares - simplywall.st

Wave Life Sciences targets fat loss without sacrificing muscle - Longevity.Technology

Insiders Sold Wave Life Sciences Prematurely At US$13.64 With Stock Trading Higher - Moomoo

Wave Life Sciences (WVE) Pulls Back 5.2% to $5.13 as Support Holds at $4.87 - Thematic ETF Flow - vinanet.vn

Wave Life Sciences Ltd. SEC Filing (Aug 17, 2026) - Stock Titan

Ähnlich wie WVE

ATTO$15.270.53%

AVBP$13.936.36%

HELP$9.3811.47%